SPRIG Equity
Olivier Delporte is currently the Chief Executive Officer at SamanTree Medical SA. With extensive experience in the medical field, Delporte has held various positions such as Board Member and CEO at Miracor Medical SA, Venture Partner at SPRIG Equity, and Board Member at Intressa Vascular and Endo Tools Therapeutics. Prior to their current role, Delporte served as Senior Vice President Sales & Marketing, International at PneumRx, Inc. and Vice-President Sales & Marketing, EMEA at Tryton Medical Inc. Delporte also has a strong educational background, holding an MBA from the University of Chicago and a degree in Ingénieur Commercial from Université catholique de Louvain.
This person is not in any teams
This person is not in any offices
SPRIG Equity
SPRIG Equity is a growth equity and late-stage venture capital firm dedicated to improving patient outcomes by partnering with best-in-class teams and technologies in the medical technology sector. We collaborate with leading innovators who are treating the most pressing challenges faces our healthcare system in the diagnostics, and digital health / tech-enabled services, and medical device sectors. SPRIG Equity is the natural extension of SPRIG Consulting, a premier HealthTech strategy and marketing consulting firm. This partnership allows us to leverage proprietary deal flow and an excellent track record to partner with companies best positioned to solve unmet needs. Having spent our careers viewing challenges from different vantage points, our entire team has unique insights that allow us to provide more than just capital to investments.